Summary of the dozens of independent laboratory tests carried out on NuvaWave technology.
Visit NanoStrike or Bipolar Ionization research.
Bacteria
Name Reduc. Salmonella typhimurium 99.95% Pseudomonas aeruginosa 99.9% MRSA 99.75% Escherichia coli (E. coli) 99.99% Enterococcus faecalis 99.96% Klebsiella pneumoniae 99.64% Acinetobacter baumannii 99.93% Viruses
Name Reduc. SARS-CoV-2 99.88% - NuvaWave Laboratory Research Summary
This booklet provides a summary of laboratory and clinical research conducted on the NuvaWave handheld device. Studies include efficacy against Virus and Bacteria including live SARS-CoV-2.
SARS-CoV-2 Virus ReductionThe NuvaWave handheld device deactivated 99.88% of SARS-CoV-2 after one second of exposure.
Salmonella typhimurium Bacteria ReductionThe NuvaWave handheld device deactivated 99.95% of Salmonella typhimurium after one second of exposure.
Pseudomonas aeruginosa Bacteria ReductionThe NuvaWave handheld device deactivated 99.9% of Pseudomonas aeruginosa after one second of exposure.
Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteria ReductionThe NuvaWave handheld device deactivated 99.75% of methicillin-resistant Staphylococcus aureus after one second of exposure.
Escherichia coli (E. coli) Bacteria ReductionThe NuvaWave handheld device deactivated 99.99% of Escherichia coli (E. coli) after one second of exposure.
Klebsiella pneumoniae Bacteria ReductionThe NuvaWave handheld device deactivated 99.64% of Klebsiella pneumoniae after one second of exposure.
Enterococcus faecalis Bacteria ReductionThe NuvaWave handheld device deactivated 99.96% of Enterococcus faecalis after one second of exposure.
Acinetobacter baumannii Bacteria ReductionThe NuvaWave handheld device reduced 99.93% of Acinetobacter baumannii after one second of exposure.